Document ID: 12834

Text:
no outstanding options, warrants, scrip, rights to subscribe to, calls, or commitments of any character whatsoever relating to, or securities or rights convertible into, or exercisable or exchangeable for, any shares of capital stock of the Company, or contracts, commitments, understandings or arrangements by which the Company is or may become bound to issue additional shares of capital stock of the Company or options, warrants, scrip, rights to subscribe to, calls, or commitments of any character whatsoever relating to, or securities or rights convertible into, or exercisable or exchangeable for, any shares of capital stock of the Company, other than those issued or granted pursuant to compensatory plans, contracts or arrangements described in the SEC Reports; except as set forth in Schedule 3.1(g), there are no material outstanding debt securities, notes, credit agreements, credit facilities or other agreements, documents or instruments evidencing indebtedness of the Company or by which the Company is bound. Except for the Registration Rights Agreement, if applicable, there are no agreements or arrangements under which the Company is obligated to register the sale of any of its securities under the Securities Act . There are no outstanding securities or instruments of the Company that contain any redemption or similar provisions, and there are no contracts, commitments, understandings or arrangements by which the Company is or may become bound to redeem a security of the Company or any of its Subsidiaries. The Company does not have any stock appreciation rights or phantom stock plans or agreements or any similar plan or agreement. Neither the Company nor any of its Subsidiaries has any liabilities or obligations required to be disclosed in the SEC Reports but not so disclosed in the SEC Reports, which, individually or in the aggregate, will have or would reasonably be expected to have a Material Adverse Effect. There are no securities or instruments issued by or to which the Company is a party containing anti-dilution or similar provisions that will be triggered by the issuance of the Shares pursuant to this Agreement and the other Transaction Documents.

Named Entities:
219
220
Act

Tokenized Text:
no
outstanding
options
,
warrants
,
scrip
,
rights
to
subscribe
to
,
calls
,
or
commitments
of
any
character
whatsoever
relating
to
,
or
securities
or
rights
convertible
into
,
or
exercisable
or
exchangeable
for
,
any
shares
of
capital
stock
of
the
Company
,
or
contracts
,
commitments
,
understandings
or
arrangements
by
which
the
Company
is
or
may
become
bound
to
issue
additional
shares
of
capital
stock
of
the
Company
or
options
,
warrants
,
scrip
,
rights
to
subscribe
to
,
calls
,
or
commitments
of
any
character
whatsoever
relating
to
,
or
securities
or
rights
convertible
into
,
or
exercisable
or
exchangeable
for
,
any
shares
of
capital
stock
of
the
Company
,
other
than
those
issued
or
granted
pursuant
to
compensatory
plans
,
contracts
or
arrangements
described
in
the
SEC
Reports
;
except
as
set
forth
in
Schedule
3
.
1
(
g
)
,
there
are
no
material
outstanding
debt
securities
,
notes
,
credit
agreements
,
credit
facilities
or
other
agreements
,
documents
or
instruments
evidencing
indebtedness
of
the
Company
or
by
which
the
Company
is
bound
.
Except
for
the
Registration
Rights
Agreement
,
if
applicable
,
there
are
no
agreements
or
arrangements
under
which
the
Company
is
obligated
to
register
the
sale
of
any
of
its
securities
under
the
Securities
Act
.
There
are
no
outstanding
securities
or
instruments
of
the
Company
that
contain
any
redemption
or
similar
provisions
,
and
there
are
no
contracts
,
commitments
,
understandings
or
arrangements
by
which
the
Company
is
or
may
become
bound
to
redeem
a
security
of
the
Company
or
any
of
its
Subsidiaries
.
The
Company
does
not
have
any
stock
appreciation
rights
or
phantom
stock
plans
or
agreements
or
any
similar
plan
or
agreement
.
Neither
the
Company
nor
any
of
its
Subsidiaries
has
any
liabilities
or
obligations
required
to
be
disclosed
in
the
SEC
Reports
but
not
so
disclosed
in
the
SEC
Reports
,
which
,
individually
or
in
the
aggregate
,
will
have
or
would
reasonably
be
expected
to
have
a
Material
Adverse
Effect
.
There
are
no
securities
or
instruments
issued
by
or
to
which
the
Company
is
a
party
containing
anti-dilution
or
similar
provisions
that
will
be
triggered
by
the
issuance
of
the
Shares
pursuant
to
this
Agreement
and
the
other
Transaction
Documents
.